论文部分内容阅读
目的 :探讨术前介入化疗的方法对 期宫颈癌患者的临床疗效观察。方法 :对 3 6例 期宫颈癌患者术前进行介入化疗 ,化疗后 14 d行宫颈癌根治术 ;另 18例 期宫颈癌患者单纯行宫颈癌根治术 ,术后分别进行疗效的观察和评定。结果 :术前介入化疗组的症状减轻率为 10 0 .0 % ,近期有效率为 10 0 .0 % ,5年生存率为 82 .6% ;单纯手术治疗组的症状减轻率为 67.8% ,近期有效率为 72 .0 % ,5年生存率为 42 .7% ,明显低于术前介入化疗组 (P<0 .0 5)。结论 :对于 期宫颈癌患者 ,采用术前介入化疗的方法可明显改善症状 ,提高近期有效率和生存期限
Objective: To investigate the clinical effect of preoperative interventional chemotherapy on patients with cervical cancer. Methods: Twenty-six patients with cervical cancer underwent preoperative chemotherapy and 14 days after chemotherapy. The other 18 patients underwent radical hysterectomy for cervical cancer. The curative effect was observed and evaluated respectively. Results: The rate of symptom relief before surgery was 100.0%, the effective rate was 100.0%, and the 5-year survival rate was 82.6%. The symptom relief rate in the surgery group was 67.8% The recent effective rate was 72.0%, and the 5-year survival rate was 42.7%, which was significantly lower than that of the preoperative chemotherapy group (P <0.05). Conclusion: For patients with cervical cancer, the use of preoperative interventional chemotherapy can significantly improve the symptoms and improve the short-term efficiency and survival